Pierre-Marie Eberst

Pierre-Marie Eberst serves as the Head of Quality for Synthesis and ADC CDMO sites at Merck Group since January 2018, overseeing quality functions across six sites involved in the manufacturing of mRNA, ADCs, HP APIs, LNPs, and fill and finish operations, as well as leading the Sterility Assurance program for Merck Life Science operations. Prior experience includes roles at Galderma - Nestlé Skin Health as Director and Head of Global Quality Management Systems, and various positions in quality assurance and compliance at Ferring Pharmaceuticals, GSK Biologicals, Nycomed Belgium, and Eli Lilly. Pierre-Marie Eberst holds an Executive Certificate in Lean Management from CentraleSupélec, a Lean Six Sigma Black Belt from the Swiss Association for Quality, a Master's in General Management from Solvay Brussels School, and a Master's in Pharmaceutical Sciences from Université libre de Bruxelles.